Aurolife Pharma, LLC recalls Glycopyrrolate Tablets, USP, 1 mg, 100 tablets, Rx Only, Distributed by: Aurobindo Pharma USA, Inc., East Windsor, NJ 0…
- Recall date
- December 16, 2022
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-0087-2023
- FDA classification
- Class II
- Brand / firm
- Aurolife Pharma, LLC
- Sold / distributed
- Nationwide in the USA and Puerto Rico.
Why it was recalled
Failed Impurities/Degradation Specifications
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Glycopyrrolate Tablets, USP, 1 mg, 100 tablets, Rx Only, Distributed by: Aurobindo Pharma USA, Inc., East Windsor, NJ 08520, NDC 13107-014-01
Get recall alerts
Free email alert whenever Aurolife Pharma, LLC has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Aurolife Pharma, LLC